Hui Tan

696 total citations · 1 hit paper
30 papers, 534 citations indexed

About

Hui Tan is a scholar working on Plant Science, Molecular Biology and Immunology. According to data from OpenAlex, Hui Tan has authored 30 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Plant Science, 11 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Hui Tan's work include Garlic and Onion Studies (12 papers), Nanoplatforms for cancer theranostics (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Hui Tan is often cited by papers focused on Garlic and Onion Studies (12 papers), Nanoplatforms for cancer theranostics (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Hui Tan collaborates with scholars based in China, Germany and United States. Hui Tan's co-authors include Dengfeng Cheng, Hongcheng Shi, Lan Yi, Qi Su, Chunfu Zhang, Hui Ling, Guobing Liu, Min Lin, Qi Su and Lifang Pang and has published in prestigious journals such as Chemical Society Reviews, ACS Nano and Biomaterials.

In The Last Decade

Hui Tan

28 papers receiving 524 citations

Hit Papers

A new era of cancer phototherapy: mechanisms and applicat... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A new era of cancer phototherapy: mechanisms and applications
    2024 58 citations Yuanwei Wang, Ke Ma et al. Chemical Society Reviews profile →

Peers

Hui Tan
Weihao Liu China
Peng Hua China
Silvia Jenni Canada
Shanshan Jiang China
Vanessa Moreno Spain
Jingyuan Sun China
Yunduo Liu China
Tapasya Srivastava India
Joe Jiang Zhu Australia
Gerald Manorek United States
Weihao Liu China
Hui Tan
Citations per year, relative to Hui Tan Hui Tan (= 1×) peers Weihao Liu

Countries citing papers authored by Hui Tan

Since Specialization
Citations

This map shows the geographic impact of Hui Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Tan more than expected).

Fields of papers citing papers by Hui Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Tan. The network helps show where Hui Tan may publish in the future.

Co-authorship network of co-authors of Hui Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Tan. A scholar is included among the top collaborators of Hui Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Tan. Hui Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Hui, Luya Cheng, Ling Yuan, et al.. (2025). Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL. Annals of Hematology. 104(5). 2823–2830.
2.
Wang, Yuanwei, Ke Ma, Miaomiao Kang, et al.. (2024). A new era of cancer phototherapy: mechanisms and applications. Chemical Society Reviews. 53(24). 12014–12042. 58 indexed citations breakdown →
3.
Wang, Yuanwei, Haifei Wen, Yixiong Gui, et al.. (2024). Advanced Nanoplatform Mediated by CRISPR-Cas9 and Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics. ACS Nano. 18(48). 33168–33180. 6 indexed citations
4.
Jiang, Xinmiao & Hui Tan. (2024). Mechanism of METTL3 in the proliferation, invasion, and migration of intrahepatic cholangiocarcinoma cells via m6A modification. Experimental Cell Research. 444(2). 114353–114353.
5.
6.
Ling, Hui, Fang Liu, Hong Xia, et al.. (2020). Diallyl disulfide induces downregulation and inactivation of cofilin�1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells. International Journal of Oncology. 56(3). 772–782. 12 indexed citations
7.
Hu, Pengcheng, Guobing Liu, Hui Tan, et al.. (2019). Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma. Frontiers in Bioengineering and Biotechnology. 7. 368–368. 26 indexed citations
8.
Sun, Jing, Linwei Li, Guoqing Li, et al.. (2018). Diallyl disulfide down‐regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells. Journal of Cellular and Molecular Medicine. 23(1). 194–204. 9 indexed citations
9.
Ling, Hui, Jie He, Hui Tan, et al.. (2017). Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide. International Journal of Oncology. 50(2). 697–707. 18 indexed citations
10.
Xu, Lili, Dengfeng Cheng, Zheyong Huang, et al.. (2017). Histamine promotes the differentiation of macrophages from CD11b+ myeloid cells and formation of foam cells through a Stat6-dependent pathway. Atherosclerosis. 263. 42–52. 15 indexed citations
11.
12.
Li, Qingye, Jing Qin, Lan Yi, et al.. (2016). Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment. Molecular Medicine Reports. 14(5). 4666–4672. 8 indexed citations
13.
Liu, Guobing, Yan Hu, Jie Xiao, et al.. (2016). 99mTc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation. Scientific Reports. 6(1). 20900–20900. 20 indexed citations
14.
Yi, Lan, Jian Shan, Xin Chen, et al.. (2016). Involvement of calreticulin in cell proliferation, invasion and differentiation in diallyl disulfide-treated HL-60 cells. Oncology Letters. 12(3). 1861–1867. 17 indexed citations
15.
Li, Xiao, Cong Wang, Hui Tan, et al.. (2016). Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials. 108. 71–80. 66 indexed citations
16.
Xiao, Jie, Xiaobo Xu, Yanli Li, et al.. (2016). Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer. Molecules. 21(10). 1308–1308. 9 indexed citations
17.
Yi, Lan, Hui Tan, Min Lin, et al.. (2010). Role of Ras‐related C3 botulinum toxin substrate 2 (Rac2), NADPH oxidase and reactive oxygen species in diallyl disulphide‐induced apoptosis of human leukaemia HL‐60 cells. Clinical and Experimental Pharmacology and Physiology. 37(12). 1147–1153. 16 indexed citations
18.
Tan, Hui, Hui Ling, Jie He, et al.. (2008). Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells. Archives of Pharmacal Research. 31(6). 786–793. 26 indexed citations
19.
Zhao, Jie, et al.. (2006). Diallyl disulfide suppresses growth of HL-60 cell through increasing histone acetylation and p21WAF1expression in vivo and in vitro. Acta Pharmacologica Sinica. 27(11). 1459–1466. 29 indexed citations
20.
Ling, Hui, Qi Su, Ying Song, et al.. (2006). Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803. Cellular & Molecular Biology Letters. 11(3). 408–23. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weihao Liu Breakdown of academic impact, for papers by Peng Hua Breakdown of academic impact, for papers by Silvia Jenni Breakdown of academic impact, for papers by Shanshan Jiang Breakdown of academic impact, for papers by Vanessa Moreno Breakdown of academic impact, for papers by Jingyuan Sun Breakdown of academic impact, for papers by Yunduo Liu Breakdown of academic impact, for papers by Tapasya Srivastava Breakdown of academic impact, for papers by Joe Jiang Zhu Breakdown of academic impact, for papers by Gerald Manorek
Rankless by CCL
2026